key: cord-0744602-nuvynt0w
authors: Jartti, Tuomas; Hasegawa, Kohei; Mansbach, Jonathan M.; Piedra, Pedro A.; Camargo, Carlos A.
title: Rhinovirus-induced bronchiolitis: Lack of association between virus genomic load and short-term outcomes
date: 2015-08-31
journal: Journal of Allergy and Clinical Immunology
DOI: 10.1016/j.jaci.2015.02.021
sha: 9d050dcbc95cfe8c58e98e0cddef92aba7ac5284
doc_id: 744602
cord_uid: nuvynt0w

nan

because rhinovirus-induced bronchiolitis/early wheezing probably is an important risk factor for recurrent wheezing and childhood asthma. 1, 2 The mechanisms behind the undesirable long-term sequela remain poorly understood, but potential factors include atopic inheritance, weak antiviral defense, and viral factors. 3 Looking closely at previous reports on quantitative rhinovirus detection, we did not find any on the rhinovirus genomic load in bronchiolitis and short-term clinical outcomes, including the need for intensive care treatment. In other conditions, however, higher rhinovirus genomic load is related to the severity and/or duration of acute lower respiratory tract illness, and 1 study reported that it discriminated the response to systemic corticosteroids in terms of less recurrent wheezing. 1, 4, 5 Data on the link between rhinovirus genomic load and clinical outcomes, however, are discordant because studies in subjects with asthma have not shown any clinical association. 6 For these reasons and the relatively small samples in earlier studies, we examined the clinical significance of rhinovirus genomic load in bronchiolitis in 694 children with severe bronchiolitis. Our aim was to prospectively investigate whether rhinovirus genomic load in standardized nasopharyngeal aspirate (NPA) samples is associated with short-term outcomes of bronchiolitis. On the basis of previous literature, our hypothesis was that higher rhinovirus genomic load in bronchiolitis is associated with worse short-term outcomes.

For this analysis, we combined data from 2 multicenter prospective cohort studies of children younger than 2 years hospitalized for bronchiolitis; both studies used the same protocol. The US study 7 Table  E1 in this article's Online Repository at www.jacionline.org), whereas the Finnish counterpart study 8 was carried out in 3 Finnish sites during the 2008-2010 winter seasons . See more details of the MARC-30 and recruitment in this article's Online Repository at www.jacionline.org. The study protocol was approved by the ethics committees of participating hospitals, and the study was commenced only after obtaining written informed consent from the guardian.

Investigators interviewed a guardian using a standard questionnaire and conducted a hospital chart review for further clinical data. NPA sampling was performed using a standardized protocol. Samples were stored at 2808C for later virus diagnostics, which included real-time PCR for adenovirus, coronaviruses NL-63, HKU1, OC43, and 229E, enterovirus, human metapneumovirus, influenza virus types A and B, 2009 novel H1N1, parainfluenza virus types 1, 2, and 3, rhinovirus, respiratory syncytial virus (RSV) A and B, Bordetella pertussis, and Mycoplasma pneumonia, as previously described. 7 Rhinovirus genomic load was quantified by using real-time RT-PCR as the number of amplification cycles needed for a positive PCR test result (cycle threshold [CT]). CT values provide a semi-quantitative measure of genomic load, with a highly significant inverse linear relationship between genomic load and CT values. See more details of the virus diagnostics in this article's Methods section in the Online Repository at www. jacionline.org.

Our primary outcome measure was hospital length of stay (LOS) of 3 days or more. 7, 8 The secondary outcome measure was intensive care treatment, defined as use of mechanical ventilation (continuous positive airway pressure and/or intubation during inpatient stay regardless of location) and/or admission to the intensive care unit. 9 Tertiles of rhinovirus CT values permitted classification into 3 rhinovirus genomic load groups: low (CT > _ 32.7), intermediate (CT, 27.2-32.6), and high (CT < 27.2). The association between rhinovirus genomic load and the outcomes was analyzed using unadjusted and multivariable logistic regression models. Several sensitivity analyses were performed to assess the robustness of the findings. All analyses were performed using SAS 9.4 (SAS Institute, Cary, NC). See more details of the outcomes and statistical methods in the Online Repository at www.jacionline.org.

Of 2615 enrolled children with bronchiolitis from 19 sites, 694 children (27%) had rhinovirus and comprised the analytic cohort (564 US children and 130 Finnish children). Among these children, the median age was 6 months (interquartile range, 3-12 months), 63% were boys, and 46% were non-Hispanic white. Two hundred sixty (37%) children had an LOS of 3 days or more, and 102 (15%) required intensive care treatment. See more details of demographics and clinical course in Tables E2 and E3 in this article's Online Repository at www.jacionline.org. Overall, there was no significant association between rhinovirus genomic load (an inverse of the CT value) and risk of LOS of 3 days or more or risk of intensive care treatment, either in unadjusted analyses or in multivariable models adjusting for 8 patient-level variables and clustering of patients within sites (all P > _.40, Fig 1, A; see Table E4 in this article's Online Repository at www.jacionline.org). Likewise, a sensitivity analysis focused on the first episode in infants younger than 12 months showed no significant associations (all P > .30; see Table E4 ). Similarly, rhinovirus genomic load had no significant associations with the outcomes, by country (see Fig E1, A and B, in this article's Online Repository at www.jacionline.org), coinfection (see Table E5 in this article's Online Repository at www.jacionline. org), atopy status (Fig 1, B; see Tables E6 and E7 in this article's Online Repository at www.jacionline.org), comorbid status (see Table E8 in this article's Online Repository at www.jacionline. org), or respiratory distress severity score (see Table E9 in this article's Online Repository at www.jacionline.org).

In summary, we found no association between rhinovirus genomic load and short-term outcomes of bronchiolitis. Our hypothesis was justified on the basis of previous clinical data, 1, 4, 5 which were also supported by in vitro data. 3 Although multiple viral infections are relatively common in severe bronchiolitis (15% to 30%), 7,8 the interplay between viruses is poorly understood. Coinfection with RSVand rhinovirus has been linked to more severe short-term outcomes of bronchiolitis compared with RSV alone, 7 but we found no link between rhinovirus genomic load, coinfections, and these same outcomes. Even when examining the rhinovirus-only group, the association was null. Moreover, investigation of the interaction between the rhinovirus genomic load and atopic status was interesting because atopic children appear to be more susceptible than nonatopic children to rhinovirus-induced wheezing. 2 Considering the large sample size, careful standardization of NPA sampling, and virus diagnostics done with the same protocol in a single laboratory, our results truly suggest no significant association between rhinovirus genomic load and an LOS of 3 days or more or need for intensive care treatment. Although 1 study suggested that rhinovirus genomic load has more clinical relevance in children older than 12 months, 4 this association is not supported by our data or other reports. 5 Because our results contrast the direct association between RSV genomic load and short-term outcomes of bronchiolitis, 10 we speculate that a host response to infection may be more important than virus load in determining the short-term clinical course of rhinovirusinduced bronchiolitis. 3 The study has potential limitations. First, bronchiolitis is a clinical diagnosis without a common international definition, 11 so we included children up to age 2 years with recurrent wheezing. Results, however, remained consistent when the analysis was restricted to children experiencing their first episode of breathing difficulty during infancy (age <12 months). Second, clinical decisions (eg, hospital admission/discharge or intensive care treatment) were not based on standardized criteria, which may have caused further variability of care. However, the significant association persisted after adjusting for clustering at the hospital level. Third, one might argue that samples from the upper respiratory tract do not reflect conditions in the lower respiratory tract and that nasal airway epithelial cells may respond differently than bronchial epithelial cells to rhinovirus infections. 12 To our knowledge, there are no data on the comparison of rhinovirus genomic load between upper and lower airway samples and their relation to symptoms. Fourth, one could also argue whether we measured the peak of rhinovirus replication due to lack of longitudinal sampling. A peak in virus concentration typically occurs at 48 to 72 hours after infection in experimental models. 13 Because the duration of prehospital symptoms is typically 1 to 3 days in rhinovirus-induced bronchiolitis, 2 our time window of the first 24 hours of the hospitalization may have been optimal. Fifth, we did not sequence rhinoviruses. 14, 15 Last, the results may not be generalizable to outpatient clinics because all our study subjects were hospitalized.

Challenges in future studies include more careful standardization of analysis (ie, standardization to housekeeping gene), investigation of viremia (ie, links to more compromised clinical outcome), virus genotyping (ie, rhinovirus species and rapid evolution of the virus), and more careful analysis of the replication/transcription status of the virus (ie, separate analysis of positive-and negative-stranded virus RNA). 5, 6 Our findings call attention to the need for more detailed analysis of virology, along with host response and genetics, when investigating predictors of short-term outcomes of severe rhinovirus-induced bronchiolitis.

To the Editor:

Chronic rhinosinusitis (CRS) is common (around 10%) in adults 1 and has been shown to be associated with reduced quality of life. 2 No study has focused on adolescents specifically. Therefore we wanted to estimate the prevalence of CRS in adolescence and evaluate the burden of symptoms.

The Swedish population-based birth cohort Barn (Children), Allergy, Milieu, Stockholm Epidemiological Study (BAMSE) consists of 4089 children recruited at a mean age of 2 months, as previously described in detail. 3 This study is based on 3112 children (76% from baseline) who participated at the 16-year follow-up (November 2010 to May 2013) and had completed the questions on CRS (see Table E1 in this article's Online Repository at www.jacionline.org). Everyone who fulfilled the criteria for CRS according to the European Position Paper on Rhinosinusitis 2007 (EP3OS) 4 was contacted by telephone, and symptoms were affirmed by a structured interview (n 5 48). The median time between questionnaire and telephone interview was 16 months.

Adolescents with ongoing symptoms (n 5 27) were asked to participate in a clinical follow-up with nasal endoscopy, 5 an olfactory threshold test (Sniffin' Sticks; Burghart Messtechnik GmbH, Wedel, Germany), 6 and the Sino-Nasal Outcome Test 22 (SNOT-22), a disease-specific quality-of-life questionnaire. 7 To compare their health-related quality-of-life (HRQoL) with that of the remaining participants of the BAMSE 16-year follow-up, the generic EQ-5D visual analog scale (VAS) was used. 8 Table E2 in this article's Online Repository at www. jacionline.org), and descriptions of Sniffin' Sticks, SNOT-22, and the EQ-VAS are presented in the Methods section in this article's Online Repository at www.jacionline.org. Nasal endoscopy was performed by 2 specialists in ear, nose, and throat diseases (M.W. and M.H.). Before application of topical anesthesia (naphazoline-lidocaine spray), inspection by means of anterior nasoscopy was performed, and afterward, endoscopy with a 08 rigid endoscope and, in some cases, fiberoptic endoscopy was performed. The estimate of the prevalence of CRS is presented in the Methods section in this article's Online Repository.

The x 2 test of independence was used for comparison of dichotomous variables. A P value of less than .050 was considered statistically significant. EQ-VAS scores are presented as median values and 25th and 75th percentiles, and median values were compared with quantile regression. All analyses were conducted with STATA Statistical Software, version 13.1 (StataCorp, College Station, Tex).

Among the 3112 16-year-olds from the BAMSE birth cohort, 43.5% reported symptoms from the upper airways during the last 12 months, but only 1.5% (n 5 48) reported symptoms of CRS (see Fig E2 in this article's Online Repository at www.jacionline. org). When the children's criteria from EPOS 2012 were used, the prevalence was 2.0% (n 5 62). Forty-two (87.5%) of the 48 adolescents fulfilled both the adult's and children's criteria. At the time of the telephone interview, 27 of the 48 adolescents still had ongoing symptoms of CRS (see Fig E1) . After the clinical examination of 23 of these 27 adolescents, 22 still fulfilled the symptom criteria of CRS, corresponding to a prevalence of 0.8% (Table I) . At clinical examination, endoscopic signs of CRS were found in 9 of the 23 adolescents, corresponding to a prevalence of 0.3%. None of the subjects had nasal polyps or enlarged adenoids or had undergone sinus surgery.

The 22 adolescents with CRS more often had allergic rhinitis symptoms (57.1% vs 28.1%, P 5.003), asthma (25.0% vs 11.0%, P 5 .047), and cough for 3 months or longer (13.6% vs 3.4%, P 5 .008) compared with those without CRS (Table I) . The median EQ-VAS score was lower compared with the rest of the population (80 vs 90, P 5 .024 and P 5 .052 after adjustment for sex; Table I 

The present analysis combines data from 2 multicenter prospective cohort studies of children hospitalized for bronchiolitis. Using a similar protocol, one study was from the United States E1 and the other was from Finland. E2 Both studies were performed as part of MARC. MARC is a program of the Emergency Medicine Network (www.emnet-usa.org), a collaboration with more than 225 participating hospitals. The study design, setting, participants, and methods of data collection used in the studies have been reported previously. E1,E2 Using a standardized protocol, we enrolled children younger than 2 years hospitalized for an attending physician's diagnosis of bronchiolitis. The exclusion criteria consisted of previous enrollment and delay of more than 48 hours in transfer to a participating hospital after the original hospitalization. All patients were treated at the discretion of the treating physician. The institutional review board at each of the participating hospitals approved the study.

For the collection of NPAs, the child was placed supine, 1 mL of normal saline was instilled into 1 naris, and an 8-F suction catheter was used to remove the mucus. This procedure was performed once on each nostril. After the sample collection from both nares, 2 mL of normal saline was suctioned through the catheter to clear the tubing and to ensure that a standard volume of aspirate was obtained. Once collected, the NPA sample was added to the transport medium. The samples were immediately placed on ice within 1 hour of collection, and then stored at 2808C within 24 hours of collection.

Real-time RT-PCR was used for the detection of RNA respiratory viruses, such as rhinovirus, RSV types A and B, parainfluenza virus types 1, 2, and 3, influenza virus types A and B, 2009 novel H1N1, human metapneumovirus, coronaviruses NL-63, HKU1, OC43, and 229E, and enterovirus. Real-time PCR was used for the detection of DNA pathogens, which included adenovirus, M pneumoniae, and B pertussis. These tests are routinely conducted in Baylor College of Medicine, and details of the primers and probes have been described previously. E3-E5 The upper and lower limits of rhinovirus detection were 15 and 40 CT, respectively. E6

For the purpose of our analyses, we focused on rhinovirus. We categorized CT values into tertiles to classify patients into 3 rhinovirus genomic load status groups: low (CT > _ 32.7), intermediate (CT, 27.2-32.6), and high (CT < 27.2). We compared patients' demographic characteristics, medical history, and hospital course by rhinovirus genomic load status using chi-square or Kruskal-Wallis tests as appropriate. To examine the association of genomic load status with the outcomes, we constructed 2 logistic regression models. First, we fitted an unadjusted model that included only genomic load status as the independent variable. Second, we constructed a multivariable model adjusting for 8 patient-level variables (ie, age, sex, race, gestational age, history of wheezing, history of eczema, comorbid medical disorder, and viral coinfection status [rhinovirus plus RSV and rhinovirus plus non-RSV pathogens]). We chose these potential confounders on the basis of clinical plausibility and a priori knowledge. E1,E2,E7 We did not adjust for markers for acute severity (eg, vital signs and retractions) or duration of symptoms before bronchiolitis hospitalization because these were considered as intermediate factors in the association of interest. In both models, we used generalized estimating equations to account for patient clustering at the hospital level.

We performed a series of sensitivity analyses to assess the robustness of our findings. First, we examined the association of rhinovirus genomic load and the primary outcome, modeling the CT value as a continuous variable, in the US cohort and the Finnish cohort separately. Second, after confirming a similar association in both the cohorts, we combined the US and Finnish data set, and then repeated the analysis by using a more restrictive definition of children with bronchiolitis-that is, those younger than 12 months and without history of wheezing. Third, we stratified the analysis by coinfection status (rhinovirus only, rhinovirus plus RSV, and rhinovirus plus non-RSV pathogens). Last, we also stratified the analysis by children's atopic status (ie, history of eczema). All analyses were performed using SAS 9.4 (SAS Institute, Cary, NC). Results are presented as proportions with 95% CIs, medians with interquartile ranges, and odds ratios with 95% CIs. All P values were 2-tailed, with P < .05 considered statistically significant. 

Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris

Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis

Filaggrin gene mutations in African Americans with both ichthyosis vulgaris and atopic dermatitis

Association screening in the epidermal differentiation complex (EDC) identifies an SPRR3 repeat number variant as a risk factor for eczema

Exome sequencing of filaggrin and related genes in African-American children with atopic dermatitis

The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis

Cutaneous biology association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population

Short-and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode

Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life

Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma

Rhinovirus load and disease severity in children with lower respiratory tract infections

Impact of rhinovirus nasopharyngeal viral load and viremia on severity of respiratory infections in children

A mechanistic role for type III IFN-l1 in asthma exacerbations mediated by human rhinoviruses

Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis

Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis

Risk factors for requiring intensive care among children admitted to ward with bronchiolitis

Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the US and Finland

American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis

In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects

Viral titers in nasal lining fluid compared to viral titers in nasal washes during experimental rhinovirus infection

Rhinovirus genome evolution during experimental human infection

Improved molecular typing assay for rhinovirus species A, B, and C

Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis

Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis

Respiratory viral infections in patients with chronic, obstructive pulmonary disease

Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection

Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation

Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses

Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation